DOPAMINE Side Effects

5166518-1 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Collagen-vascular Disease, Connective Tissue Disorder, Crepitations, Cyanosis, Depressed Level Of Consciousness, Dyspnoea, Gangrene
on Nov 17, 2006 Male patient from NEPAL , 45 years of age, was diagnosed with shock, hypotension and was treated with Dopamine (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, collagen-vascular disease, connective tissue disorder (What is connective tissue disorder?), crepitations, cyanosis, depressed level of consciousness, dyspnoea, gangrene. Dopamine dosage: 10 Mcg/kg Per Minute Iv. During the same period patient was treated with CEFTAZIDIME (View Ceftazidime Review and Ceftazidime Label ), CLOXACILLIN SODIUM (View Cloxacillin Sodium Review and Cloxacillin Sodium Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), PHENYTOIN SODIUM CAP (View Phenytoin Sodium Cap Review and Phenytoin Sodium Cap Label ), PHENOBARBITONE (View Phenobarbitone Review and Phenobarbitone Label ).

5150993-2 | Left Ventricle Outflow Tract Obstruction, Mitral Valve Incompetence
Patient was taking Dopamine (View Usage). Patient had the following side effects: left ventricle outflow tract obstruction, mitral valve incompetence on Oct 24, 2006 from SPAIN Additional patient health information: Female patient , 63 years of age, was diagnosed with haemodynamic instability, hypotension, sinus tachycardia and. Dopamine dosage: .

4894718-4 | Accidental Exposure, Incorrect Dose Administered, Pulse Absent, Respiratory Arrest
Adverse event was reported on Jan 27, 2006 by a Female patient taking Dopamine (View Usage) (Dosage: 3 Mcg/kg/min-x 2 Cadd Cassett Iv) was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Location: UNITED STATES , 54 years of age, After Dopamine was administered, patient had the following side effects: accidental exposure, incorrect dose administered, pulse absent, respiratory arrest. During the same period patient was treated with CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), EPOSPROSTENOL (View Eposprostenol Review and Eposprostenol Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), ALPROAZOLAM (View Alproazolam Review and Alproazolam Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), SILDENAFIL (View Sildenafil Review and Sildenafil Label ). Patient was hospitalized.

4846678-X | Acute Respiratory Distress Syndrome, Cardiac Disorder, Electrocardiogram St Segment Elevation, Hyponatraemia, Vasoconstriction
on Nov 18, 2005 Male patient from HUNGARY , 59 years of age, weighting 119.0 lb, was diagnosed with shock and was treated with Dopamine (View Usage). Patient experienced the following unwanted or unexpected effects: acute respiratory distress syndrome, cardiac disorder, electrocardiogram st segment elevation, hyponatraemia, vasoconstriction. Dopamine dosage: . During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), DORMICUM (View Dormicum Review and Dormicum Label ), STEROFUNDIN (View Sterofundin Review and Sterofundin Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), HEPARIN SODIUM (View Heparin Sodium Review and Heparin Sodium Label ). Patient was hospitalized.


4823535-6 | Hypotension, Medical Device Complication
on Oct 20, 2005 Female patient from UNITED STATES , weighting 134.5 lb, was treated with Dopamine (View Usage). Patient had the following side effects: hypotension, medical device complication. Dopamine dosage: 15 Ug/kg; Iv. During the same period patient was treated with NOREPINEPHRINE (View Norepinephrine Review and Norepinephrine Label ).

4791149-2 | Arteriospasm Coronary
Patient was taking Dopamine (View Usage). After Dopamine was administered, patient had the following side effects: arteriospasm coronary on Sep 19, 2005 from HUNGARY Additional patient health information: Male patient , 48 years of age, . Dopamine dosage: 15. During the same period patient was treated with MEDROL (500 Mg) (View Medrol Review and Medrol Label ).

4761062-5 | Electrocardiogram St Segment Elevation, Shock, Vasoconstriction
Adverse event was reported on Aug 19, 2005 by a Male patient taking Dopamine (View Usage) (Dosage: ) . Location: HUNGARY , 48 years of age, Patient experienced the following unwanted or unexpected effects: electrocardiogram st segment elevation, shock, vasoconstriction.